Mitral regurgitation is an independent predictor of 1-year mortality in ST-elevation myocardial infarction patients presenting in cardiogenic shock on admission.

Acute Cardiac Care

Volumn 12, Issue 2, 2010, Pages 51-57

  Engstrm, Annemarie E ^a   Vis, Marije M ^a   Bouma, Berto J ^a   Claessen, Bimmer E P M ^a   Sjauw, Krischan D ^a   Baan Jr , Jan ^a   Meuwissen, Martijn ^a   Koch, Karel T ^a   De Winter, Robbert J ^a   Tijssen, Jan G P ^a   Piek, Jan J ^a   Henriques, José P S ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

Cardiogenic shock; Mitral regurgitation; Myocardial infarction; Percutaneous coronary intervention

Indexed keywords

ADULT; AGE DISTRIBUTION; ARTICLE; CARDIOGENIC SHOCK; COLOR ULTRASOUND FLOWMETRY; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HEART LEFT VENTRICLE EJECTION FRACTION; HOSPITAL ADMISSION; HUMAN; MAJOR CLINICAL STUDY; MALE; MITRAL VALVE REGURGITATION; MITRAL VALVE REPAIR; MORTALITY; NO REFLOW PHENOMENON; PERCUTANEOUS CORONARY INTERVENTION; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; RISK ASSESSMENT; SEX DIFFERENCE; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION;

AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; COHORT STUDIES; ECHOCARDIOGRAPHY, DOPPLER, COLOR; ELECTROCARDIOGRAPHY; EMERGENCY SERVICE, HOSPITAL; FEMALE; HOSPITALIZATION; HUMANS; MALE; MIDDLE AGED; MITRAL VALVE INSUFFICIENCY; PREDICTIVE VALUE OF TESTS; RISK FACTORS; SEVERITY OF ILLNESS INDEX; SHOCK, CARDIOGENIC; SURVIVAL RATE;

EID: 77952699985     PISSN: 17482941     EISSN: 1748295X     Source Type: Journal    
DOI: 10.3109/17482941003802148     Document Type: Article

References (29)

1. Goldberg RJ, Samad NA, Yarzebski J, Gurwitz J, Bigelow C, Gore JM. Temporal trends in cardiogenic shock complicating acute myocardial infarction. N Engl J Med. 1999;340:1162-1168
2. Hochman JS, Sleeper LA, Webb JG, Sanborn TA, White HD, Talley JD, et al. Early revascularization in acute myocardial infarction complicated by cardiogenic shock. SHOCK investigators. Should we emergently revascularize occluded coronaries for cardiogenic shock. N Engl J Med. 1999;341:625-634
3. Hochman JS, Sleeper LA, Webb JG, Dzavik V, Buller CE, Aylward P, et al. Early revascularization and long-term survival in cardiogenic shock complicating acute myocardial infarction. JAMA 2006;295:2511-2515
4. Babaev A, Frederick PD, Pasta DJ, Every N, Sichrovsky T, Hochman JS. Trends in management and outcomes of patients with acute myocardial infarction complicated by cardiogenic shock. JAMA 2005;294:448-454
5. Lamas GA, Mitchell GF, Flaker GC, Smith SC, Jr, Gersh BJ, Basta L, et al. Clinical Significance of mitral regurgitation after acute myocardial infarction. Survival and ventricular enlargement investigators. Circulation 1997;96:827-833
6. Barzilai B, Gessler C, Jr, Perez JE, Schaab C, Jaffe AS. Significance of Doppler-detected mitral regurgitation in acute myocardial infarction. Am J Cardiol. 1988;61:220-223
7. Pellizzon GG, Grines CL, Cox DA, Stuckey T, Tcheng JE, Garcia E, et al. Importance of mitral regurgitation inpatients undergoing percutaneous coronary intervention for acute myocardial infarction: The controlled abciximab and device investigation to lower late angioplasty complications (CADILLAC) trial. J Am Coll Cardiol. 2004;43:1368-1374 (Pubitemid 38496340)
8. Feinberg MS, Schwammenthal E, Shlizerman L, Porter A, Hod H, Friemark D, et al. Prognostic Significance of mild mitral regurgitation by color Doppler echocardiography in acute myocardial infarction. Am J Cardio. 2000;86:903.
9. Lehmann KG, Francis CK, Dodge HT. Mitral regurgitation in early myocardial infarction. Incidence, clinical detection, and prognostic implications. TIMI Study Group. Ann Intern Med.1992;117:10-17
10. Tcheng JE, Jackman JD, Jr, Nelson CL, Gardner LH, Smith LR, Rankin JS, et al. Outcome of patients sustaining acute ischemic mitral regurgitation during myocardial infarction. Ann Intern Med.1992;117:18-24
11. Amigoni M, Meris A, Thune JJ, Mangalat D, Skali H, Bourgoun M, et al. Mitral regurgitation in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both: Pognostic Significance and relation to ventricular size and function. Eur Heart J.2007;28:326-333
12. Pastorius CA, Henry TD, Harris KM. Long-term outcomes of patients with mitral regurgitation undergoing percutaneous coronary intervention. Am J Cardiol.2007;100:1218-1223
13. Vis MM, Sjauw KD, van der Schaaf RJ, Baan J, Jr., Koch KT, DeVries JH, et al. In patients with ST-segment elevation myocardial infarction with cardiogenic shock treated with percutaneous coronary intervention, admission glucose level is a strong independent predictor for 1-year mortality in patients without a prior diagnosis of diabetes. Am Heart J. 2007;154:1184-1190
14. Vis MM, Sjauw KD, van der Schaaf RJ, Koch KT, Baan J, Jr, Tijssen JG, et al. Prognostic value of admission hemoglobin levels in ST-segment elevation myocardial infarction patients presenting with cardiogenic shock. Am J Cardiol. 2007;99:1201-1202
15. Bonow RO, Carabello BA, Chatterjee K, de LA, Jr, Faxon DP, Freed MD, et al. ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing Committee to Revise the 1998 guidelines for the management of patients with valvular heart disease) developed in collaboration with the Society of Cardiovascular Anesthesiologists endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons. J Am Coll Cardiol. 2006;48:e1-148.
16. Picard MH, Davidoff R, Sleeper LA, Mendes LA, Thompson CR, Dzavik V, et al. Echocardiographic predictors of survival and response to early revascularization in cardiogenic shock. Circulation 2003;107:279-284
17. Hillis GS, Moller JE, Pellikka PA, Bell MR, Casaclang- Verzosa GC, Oh JK. Prognostic Significance of echocardiographically defi ned mitral regurgitation early after acute myocardial infarction. Am Heart J. 2005;150:1268-1275
18. Feldman T, Wasserman HS, Herrmann HC, Gray W, Block PC, Whitlow P, et al. Percutaneous mitral valve repair using the edge-to-edge technique: six-month results of the EVEREST Phase I Clinical Trial. J Am Coll Cardiol. 2005;46:2134-2140
19. Liddicoat JR, MacNeill BD, Gillinov AM, Cohn WE, Chin CH, Prado AD, et al. Percutaneous mitral valve repair: A feasibility study in an ovine model of acute ischemic mitral regurgitation. Catheter Cardiovasc Interv. 2003;60: 410-416
20. Webb JG, Harnek J, Munt BI, Kimblad PO, Chandavimol M, Thompson CR, et al. Percutaneous transvenous mitral annuloplasty: Initial human experience with device implantation in the coronary sinus. Circulation 2006;113:851-855
21. Otsuji Y, Handschumacher MD, Liel-Cohen N, Tanabe H, Jiang L, Schwammenthal E, et al. Mechanism of ischemic mitral regurgitation with segmental left ventricular dysfunction: three-dimensional echocardiographic studies in models of acute and chronic progressive regurgitation. J Am Coll Cardiol. 2001;37:641-648
22. Carrabba N, Parodi G, Valenti R, Shehu M, Migliorini A, Memisha G, et al. Clinical implications of early mitral regurgitation in patients with reperfused acute myocardial infarction. J Card Fail. 2008;14:48-54.
23. Grossman W, Jones D, McLaurin LP. Wall stress and patterns of hypertrophy in the human left ventricle. J Clin Invest. 1975;56:56-64.
24. van't Hof AW, Liem AL, de Boer MJ, Hoorntje JC, Suryapranata H, Zijlstra F. A randomized comparison of intra-aortic balloon pumping after primary coronary angioplasty in high risk patients with acute myocardial infarction. Eur Heart J. 1999;20:659-665
25. Stone GW, Marsalese D, Brodie BR, Griffi n JJ, Donohue B, Costantini C, et al. A prospective, randomized evaluation of prophylactic intraaortic balloon counterpulsation in high risk patients with acute myocardial infarction treated with primary angioplasty. Second Primary Angioplasty in Myocardial Infarction (PAMI-II) Trial Investigators. J Am Coll Cardiol. 2008;51:1044-1046
26. Sjauw KD, Remmelink M, Baan Jr J, Lam KY, Engström AE, van der Schaaf RJ, et al. Left ventricular unloading in acute STEMI patients is safe and feasible and provides acute and sustained left ventricular recovery. The AMC MACH 2 study. J Am Coll Cardiol. 2007;.
27. Catena E, Milazzo F, Merli M, Paino R, Garatti A, Colombo T, et al. Echocardiographic evaluation of patients receiving a new left ventricular assist device: The Impella recover 100. Eur J Echocardiogr. 2004;5:430-437 (Pubitemid 40045648)
28. Thompson CR, Buller CE, Sleeper LA, Antonelli TA, Webb JG, Jaber WA, et al. Cardiogenic shock due to acute severe mitral regurgitation complicating acute myocardial infarction: a report from the SHOCK Trial Registry. Should we use emergently revascularize occluded coronaries in cardiogenic shock? J Am Coll Cardiol. 2000;36(Suppl. A):1104-1109
29. Bouki KP, Pavlakis G, Papasteriadis E. Management of cardiogenic shock due to acute coronary syndromes. Angiology 2005;56:123-130